SCHEDULE: Vanguard Trims Anterix Stake to Just Under 5%

The Vanguard Group has reported a 4.97% beneficial ownership stake in Anterix Inc. following an internal realignment.

Summary

• The Vanguard Group holds 931,305 shares of Anterix Inc. Common Stock.
• This represents 4.97% of the class of securities, falling just below the 5% reporting threshold for new filings.
• Vanguard has shared voting power over 121,172 shares and shared dispositive power over 931,305 shares.
• An internal realignment at The Vanguard Group, Inc. effective January 12, 2026, means it no longer directly performs portfolio management or administers proxy voting.
• Subsidiaries or business divisions of Vanguard are expected to report beneficial ownership separately on a disaggregated basis going forward.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Anterix Inc.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While Vanguard remains a significant shareholder, the reduction to just under 5% means less frequent public disclosure from them regarding this specific holding, which could be seen as a minor negative for transparency.

Positives

• Vanguard, a major institutional investor, maintains a significant stake in Anterix Inc., indicating continued investment interest.
• The holding is for investment purposes in the ordinary course of business, not for control, suggesting stability in the ownership structure.

Negatives

• The reported ownership of 4.97% is just below the 5% threshold, indicating a reduction in The Vanguard Group's stake from a previous filing.
• Falling below the 5% threshold means less frequent public disclosure from Vanguard regarding this specific holding in the future, potentially reducing transparency for other investors.

Risks

• The internal realignment at The Vanguard Group, effective January 12, 2026, could lead to disaggregated reporting by its subsidiaries, potentially making it more complex to track the aggregate Vanguard holding in Anterix Inc. in the future.
• The reduction of The Vanguard Group's beneficial ownership to below 5% could be interpreted as a slight decrease in conviction or a rebalancing of portfolios, which might signal a potential lack of strong upside in the near term.

Future Outlook

The Vanguard Group anticipates that certain subsidiaries or business divisions will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on SEC Release No. 34-39538. These subsidiaries will continue to pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment.

Management Comments

• "On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. As of that date, The Vanguard Group, Inc. no longer performs portfolio management services or administers proxy voting."
• "The Vanguard Group, Inc. anticipates that certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that currently have, or are deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release."
• "These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment."
• "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities."

Industry Context

StockSavvy.ai notes that institutional ownership by major asset managers like The Vanguard Group is a common indicator of a company's investability and liquidity. A slight reduction in stake, bringing it just under the 5% threshold, is a routine portfolio adjustment for large funds, often driven by rebalancing or specific fund mandates rather than a fundamental change in the issuer's prospects. However, it does mean less frequent public disclosure from Vanguard regarding this specific holding.

Comparison to Industry Standards

• StockSavvy.ai observes that a 4.97% stake by a major institutional investor like Vanguard is still a substantial holding, though it falls below the 5% threshold that typically triggers more frequent reporting requirements for passive investors.
• Compared to other large-cap companies where Vanguard often holds 7-10% or more, this stake in Anterix Inc. is relatively smaller, suggesting it might be a less concentrated position within Vanguard's broader portfolio.
• For example, Vanguard's holdings in companies like Apple Inc. or Microsoft Corp. often exceed 8% of the outstanding shares, reflecting their broad market index strategies. The Anterix stake, while significant, is not at that level.

Stakeholder Impact

• Shareholders: The reduction in Vanguard's stake to below 5% means less frequent public updates on their specific holding, potentially reducing transparency for other investors. However, Vanguard remains a significant institutional holder, which can provide some stability.

Next Steps

• The Vanguard Group's subsidiaries or business divisions are expected to report beneficial ownership separately on a disaggregated basis in the future.

Key Dates

Recommendation

The filing indicates a routine adjustment by a large institutional investor, The Vanguard Group, reducing its stake in Anterix Inc. to just under 5%. This is not indicative of a strong positive or negative fundamental change in Anterix Inc.'s business. While the reduction below 5% means less frequent public disclosure from Vanguard on this specific holding, it doesn't suggest a significant shift in investment thesis that would warrant a "buy" or "sell" recommendation based solely on this filing. Therefore, a "hold" recommendation is appropriate, advising investors to maintain their current position while monitoring other company-specific and industry developments.

Keywords

Anterix Inc, Vanguard Group, Schedule 13G, beneficial ownership, institutional investor, common stock, equity stake, passive investment, 03676C100